Feb 4 • 08:06 UTC 🇩🇰 Denmark Politiken

Novo Nordisk in a bloodbath on the stock market

Novo Nordisk's shares plummeted 18% following the release of its 2025 annual report, which revealed disappointing growth expectations for 2026.

📡 Similar Coverage